Tumor retarding (1,2-diphenyl-ethylenediamine)-platinum(II)-complexes
    1.
    发明授权
    Tumor retarding (1,2-diphenyl-ethylenediamine)-platinum(II)-complexes 失效
    抗肿瘤剂(1,2-二苯基 - 乙二胺) - 铂(II) - 复合物

    公开(公告)号:US4730068A

    公开(公告)日:1988-03-08

    申请号:US831913

    申请日:1986-02-21

    摘要: There are disclosed antitumor active 1,2-diphenyl-ethylenediamine)-platinum(II)-complex of the general formula ##STR1## wherein R.sub.7 is hydrogen or C.sub.1 -C.sub.6 -alkyl and R.sub.2 is either (1) a halogen atom and the groups R.sub.1, R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are the same or different and are hydrogen, halogen, trihalomethyl, C.sub.1 -C.sub.6 -alkyl, hydrogen C.sub.1 -C.sub.6 -alkoxy, a C.sub.2 -C.sub.6 -alkanoyloxy or a halo or C.sub.1 -C.sub.4 -alkanesulfonyloxy substituted C.sub.2 -C.sub.6 -alkanoyloxy group, or R.sub.2 is (2) a hydroxy group, a C.sub.1 -C.sub.6 -alkoxy group, a C.sub.2 -C.sub.6 -alkanoyloxy group in the 4-position or a halo or C.sub.1 -C.sub.4 -alkanesulfonyloxy substituted C.sub.2 -C.sub.6 -alkanoyloxy group and if R.sub.2 is (2) then the groups R.sub.1 and R.sub.3 which are the same or differnt are in the 2 and 6 positions of the phenyl group and are halogen, trihalomethyl, C.sub.1 -C.sub.6 -alkyl, hydroxy, a C.sub.1 -C.sub.6 -alkoxy, C.sub.2 -C.sub.6 -alklanoyloxy group or a halo or C.sub.1 -C.sub.5 -alkanesulfonyloxy substituted C.sub.2 -C.sub.6 -alkanoyloxy group, with the proviso that R.sub.1 can also be hydrogen and the groups R.sub.4, R.sub.5, and R.sub.6 are the same or different and are hydrogen, halogen, trihalomethyl, C.sub.1 -C.sub.6 -alkyl, hydroxy, C.sub.1 -C.sub.6 -alkoxy, a C.sub.2 -C.sub.6 -alkanoyloxy group or a halo or C.sub.1 -C.sub.4 -alkanesulfonyloxy substituted C.sub.2 -C.sub.6 -alkanoyloxy group and X is the equivalent of a physiologically compatible anion and process of their production.

    摘要翻译: 公开了具有通式“IMAGE”I的抗肿瘤活性的1,2-二苯基 - 乙二胺) - 铂(II) - 复合物,其中R 7是氢或C 1 -C 6 - 烷基,R 2是(1)卤素原子, 基团R 1,R 3,R 4,R 5和R 6相同或不同,为氢,卤素,三卤甲基,C 1 -C 6 - 烷基,C 1 -C 6 - 烷氧基,C 2 -C 6 - 烷酰氧基或卤素或C 1 -C 4 - 烷磺酰氧基取代的C 2 -C 6 - 烷酰氧基,或R 2为(2)羟基,C 1 -C 6 - 烷氧基,C 4 -C 6 - 烷酰氧基或卤素或C 1 -C 4 - 烷磺酰氧取代 C 2 -C 6 - 烷酰氧基,如果R 2为(2),则相同或不同的基团R 1和R 3为苯基的2和6位,为卤素,三卤代甲基,C 1 -C 6烷基,羟基, C 1 -C 6 - 烷氧基,C 2 -C 6 - 烷酰氧基或卤素或C 1 -C 5 - 烷磺酰氧基取代的C 2 -C 6 - 烷酰氧基,条件是R 1也可以是氢,基团R 4,R 5和R 6是 相同或不同的 氢,卤素,三卤代甲基,C 1 -C 6 - 烷基,羟基,C 1 -C 6 - 烷氧基,C 2 -C 6 - 烷酰氧基或卤素或C 1 -C 4 - 烷磺酰氧基取代的C 2 -C 6 - 烷酰氧基,X等同于 生理上相容的阴离子及其生产方法。

    (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds
    2.
    发明授权
    (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds 失效
    (1,2-二苯基) - 乙二胺) - 铂(II)络合物

    公开(公告)号:US4598091A

    公开(公告)日:1986-07-01

    申请号:US580238

    申请日:1984-02-15

    CPC分类号: C07F15/0093

    摘要: There are prepared antitumor active (1,2-diphenyl-ethylenediamine)-platinum (II) complex compounds of the formula ##STR1## where the groups R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are the same or different and are hydrogen, hydroxy groups, C.sub.1 -C.sub.6 -alkoxy groups, C.sub.2 -C.sub.6 -alkanoyloxy groups which optionally are substituted by halogen atoms or C.sub.1 -C.sub.4 -alkanesulfonyloxy groups or C.sub.3 -C.sub.6 -alkenoyloxy groups and at least one of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 is not hydrogen and X is the equivalent of a physiologically compatible or pharmaceutically acceptable anion.

    摘要翻译: 制备式Ⅰ的抗肿瘤活性(1,2-二苯基 - 乙二胺) - 铂(II)配合物,其中基团R 1,R 2,R 3和R 4相同或不同,为氢,羟基, C 1 -C 6烷氧基,任选被卤素原子或C 1 -C 4烷基磺酰氧基或C 3 -C 6 - 烯酰氧基取代的C 2 -C 6 - 烷酰氧基,R 1,R 2,R 3和R 4中的至少一个不是氢, X相当于生理上相容或药学上可接受的阴离子。